15
- Societies
- SSH
- Categories
- Session
Oral presentations Hemostasis, transfusion medicine, vascular, laboratory medicine, benign hematology
-
Is dual targeting of FXII and Gas6 a good strategy to prevent thrombosis with no risks of bleeding?
- Presentation time:
- 10 min
- Discussion time:
- 4 min
Speaker: Tripodo (Inselspital)
-
Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Fourth interim analysis of the non-interventional study EMIIL
- Presentation time:
- 10 min
- Discussion time:
- 4 min
-
Temporal phosphoproteomics reveals key regulators of procoagulant COAT platelet generation
- Presentation time:
- 10 min
- Discussion time:
- 4 min
-
Modulation of protein S benefits joint integrity and bone health in hemophilia A
- Presentation time:
- 10 min
- Discussion time:
- 4 min
Speaker: Prince-Eladnani (Inselspital)
-
NET formation contributes to clinical relapses but not ADAMTS13 biomarker relapses in immune-mediated thrombotic thrombocytopenic purpura (iTTP)
- Presentation time:
- 10 min
- Discussion time:
- 4 min
Speaker: Buonomo (Inselspital)
-
Clinical impact of pathogen-reduced platelet concentrates stored for up to 7 days in routine use in patients receiving allogeneic haematopoietic stem cell transplantation in Switzerland
- Presentation time:
- 10 min
- Discussion time:
- 4 min
Speaker: Kopp (University Hospital Basel)